No, lots of people holding for 2-3 like me probably. The recent round of funding at 1.68 more orless sealed it for me that this is a long-term play, this stock/co has a better pipeline of drugs than celltech, now much is their mkt cap compared to azm/pro/prm etc?

DYOR but this an excellent stock to hold, look how acambis has moved over the lat 12-18mths excpect more from azm, obesity is a major major problem in the US, it's worth a lot!

i think it still looking good. but most of the news already dried up and need new news comming it to push it higher. I think most of the ppl holiding it is target at around 2 to 3 pound.

correct

Look at the 1 month chart, suspect another push to 2, could break 1.9 v.soon., news must be on the horizon.